In pediatric precursor B-ALL, the frequency of ZNF384 gene rearrangement is approximately 3% [55], and its prognostic impact is considered intermediate but can vary depending on the partner genes involved. Here, ZNF384 is linked to acute lymphoblastic leukemia.